Beta Bionics CFO Stephen Feider sells $127,579 in stock

Stephen Feider, the Chief Financial Officer of Beta Bionics, sold 6,675 shares of the company's common stock on September 2, 2026, for a total of $127,579. This sale was performed to satisfy tax withholding requirements related to the vesting of restricted stock units. The shares were traded at varying prices, ranging from $18.89 to $19.545, with an average sale price of $19.1131 per share.

The recent surge in Beta Bionics' stock price, which has increased by 72% over the past six months, has led the stock to trade at $19.92, with a market capitalization of $873 million. InvestingPro analysis indicates that the stock is trading above its Fair Value, implying limited potential for further price appreciation. Following this sale, Feider's direct beneficial ownership in Beta Bionics now stands at 159,378 shares of common stock.